GWS
MRNA icon

Glassman Wealth Services’s Moderna MRNA Stock Holding History

Glassman Wealth Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-132
Closed -$13.1K – 1184
2023
Q4 		$13.1K Sell
132
-251
-66% -$21.1K ﹤0.01% 805
2023
Q3 		$39.6K Buy
383
+46
+14% +$5.13K 0.01% 477
2023
Q2 		$40.9K Buy
337
+95
+39% +$12.7K 0.01% 451
2023
Q1 		$37.2K Sell
242
-128
-35% -$21.1K 0.01% 474
2022
Q4 		$66.5K Buy
370
+130
+54% +$21.3K 0.01% 355
2022
Q3 		$28K Sell
240
-100
-29% -$15.2K 0.01% 529
2022
Q2 		$49K Buy
340
+75
+28% +$10.7K 0.01% 403
2022
Q1 		$46K Buy
265
+97
+58% +$16.3K 0.01% 420
2021
Q4 		$43K Sell
168
-192
-53% -$56.1K 0.01% 404
2021
Q3 		$139K Buy
360
+43
+14% +$15.9K 0.03% 190
2021
Q2 		$74K Buy
317
+10
+3% +$1.79K 0.02% 282
2021
Q1 		$40K Buy
307
+43
+16% +$6.23K 0.01% 369
2020
Q4 		$28K Buy
264
+52
+25% +$5.26K 0.01% 440
2020
Q3 		$15K Buy
212
+35
+20% +$2.44K ﹤0.01% 513
2020
Q2 		$11K Buy
177
+61
+53% +$3.34K ﹤0.01% 478
2020
Q1 		$3K Buy
+116
New +$2.67K ﹤0.01% 628
2019
Q3 		– Sell
-13
Closed – – 1251
2019
Q2 		$0 Buy
+13
New +$279 ﹤0.01% 1254

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Glassman Wealth Services's MRNA Position: Q1 2024 in Review

Glassman Wealth Services sold out of Moderna (MRNA) in Q1 2024, closing a stake of 132 shares — an estimated $13.1K sold.

Glassman Wealth Services first reported a position in MRNA in Q2 2019 and held it in 17 quarters. The position peaked at $139K in Q3 2021. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Glassman Wealth Services reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 132 Moderna shares in Q1 2024, an estimated $13.1K.
  • Glassman Wealth Services first reported a position in Moderna in Q2 2019 and held it in 17 quarters.
  • Glassman Wealth Services's Moderna position peaked at $139K in Q3 2021.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.